In the post COVID-19 pandemic health care emergency era, private and public insurance entities will continue full coverage of the shots - but what about the uninsured?
What will be the impact on patients and your practice this fall when the federal government no longer pays for and gives away free COVID-19 vaccines and the antiviral Paxlovid?
COVID-19 is here to stay and the Vaccines and Related Biological Products Committee of the US Food and Drug Administration (FDA) voted unanimously on June 15 that vaccines for the 2023-2024 respiratory virus season should be updated to a monovalent vaccine against the Omicron variant XBB.1.5 that currently accounts for approximately 40% of new COVID infections. Pfizer, Moderna, and Novavax have already been working on producing that vaccine and Pfizer announced on June 231 that along with partner BioNTech the companies have submitted regulatory applications to the FDA.
References
FDA Proposed Rule Would Limit Nicotine Content in Cigarettes, Cigars, Other Combusted Products
January 16th 2025The agency estimates that limiting nicotine levels could lead to 1.8 million fewer tobacco-related deaths by 2060 and health care savings of $1.1 trillion a year over the next 40 years.